ANTITUMOR EFFECTS OF A NEW POLYSACCHARIDE-PROTEIN COMPLEX (ATOM) PREPARED FROM AGARICUS-BLAZEI (IWADE STRAIN-101) HIMEMATSUTAKE AND ITS MECHANISMS IN TUMOR-BEARING MICE
H. Ito et al., ANTITUMOR EFFECTS OF A NEW POLYSACCHARIDE-PROTEIN COMPLEX (ATOM) PREPARED FROM AGARICUS-BLAZEI (IWADE STRAIN-101) HIMEMATSUTAKE AND ITS MECHANISMS IN TUMOR-BEARING MICE, Anticancer research, 17(1A), 1997, pp. 277-284
The antitumor activity of the i.p. or p.o. administration of polysacch
aride-protein complex, ATOM (antitumor organic substance Mie) prepared
from cultured mycelia of Agaricus blazei (Iwade strain 101) ''Himemat
sutake'' examined against four kinds of established mouse tumors. ATOM
was highly effective at the doses of 10 and 20 mg/kg/day x 10 on subc
utaneously implanted Sarcoma 180 in mice, and was also active against
Ehrlich ascites carcinoma, Shionogi carcinoma 42 and Meth A fibrosarco
ma at doses of 50 and 100 mg/kg/day x 10. ATOM has no direct cytotoxic
action on tumor cells in vitro. Thus the tumor growth-inhibitory effe
ct of ATOM is apparently due to immunological host-mediated mechanisms
. The number of peritoneal macrophages, the phagocytosis of polystyren
e latex beads and the proportion of the third component of complement
(C3)-positive fluorescent cells were increased in the mice treated wit
h ATOM. These results suggest that the macrophage activa-tion and alte
rations of the C3 are necessary for the induction of an antitumor effe
ct of ATOM.